These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6197374)

  • 1. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of aprotinin, a kallikrein inhibitor in rats in saline diuresis.
    Kauker ML
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):222-6. PubMed ID: 2578672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
    Vemulapalli S; Chiu PJ
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal kallikrein in control of renin release in conscious rats.
    Kobayashi M; Suzuki S; Hashiba K
    Am J Physiol; 1983 Mar; 244(3):E262-5. PubMed ID: 6187220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental nephron function in rats treated with aprotinin, an inhibitor of kallikrein.
    Kauker ML; Nasjletti A
    J Pharmacol Exp Ther; 1986 Jul; 238(1):155-8. PubMed ID: 3636397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB; Mikhaĭlenko PV; Kriukova RA
    Farmakol Toksikol; 1986; 49(2):21-4. PubMed ID: 2423364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats.
    Yoshida M; Suzuki-Kusaba M; Satoh S
    Ren Physiol; 1987; 10(1):25-32. PubMed ID: 2446364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the natriuretic effect of nifedipine in hypertensive patients: increase in levels of plasma atrial natriuretic factor without participation of the renal kallikrein-kinin system.
    Rappelli A; Dessì-Fulgheri P; Madeddu P; Glorioso N
    J Hypertens Suppl; 1987 Dec; 5(4):S61-5. PubMed ID: 2450187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the role of kidney kallikrein on bumetanide induced diuresis in rats.
    Olsen UB
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):321-6. PubMed ID: 6179386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aprotinin on renal function in chronic hypoxic rats.
    Chen CF; Chen LW; Chien CT
    Chin J Physiol; 1995; 38(1):23-6. PubMed ID: 8549232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
    MacGilchrist A; Craig KJ; Hayes PC; Cumming AD
    Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation by aprotinin of the renal response to vasopressin.
    Kauker ML; Baer PG; Nasjletti A
    Kidney Int; 1987 May; 31(5):1092-6. PubMed ID: 2439737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the protease inhibitor aprotinin on renal hemodynamics in the pig.
    Maier M; Starlinger M; Zhegu Z; Rana H; Binder BR
    Hypertension; 1985; 7(1):32-8. PubMed ID: 2579904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.